William Harvey Research Institute, Queen Mary University of London, London, UK.
Reconstructive Surgery and Regenerative Medicine Research Group, Institute of Life Sciences, Swansea University Medical School, Swansea, UK.
Br J Surg. 2021 Jan 27;108(1):97-103. doi: 10.1093/bjs/znaa012.
The COVID-19 response required the cancellation of all but the most urgent surgical procedures. The number of cancelled surgical procedures owing to Covid-19, and the reintroduction of surgical acivirt, was modelled.
This was a modelling study using Hospital Episode Statistics data (2014-2019). Surgical procedures were grouped into four urgency classes. Expected numbers of surgical procedures performed between 1 March 2020 and 28 February 2021 were modelled. Procedure deficit was estimated using conservative assumptions and the gradual reintroduction of elective surgery from the 1 June 2020. Costs were calculated using NHS reference costs and are reported as millions or billions of euros. Estimates are reported with 95 per cent confidence intervals.
A total of 4 547 534 (95 per cent c.i. 3 318 195 to 6 250 771) patients with a pooled mean age of 53.5 years were expected to undergo surgery between 1 March 2020 and 28 February 2021. By 31 May 2020, 749 247 (513 564 to 1 077 448) surgical procedures had been cancelled. Assuming that elective surgery is reintroduced gradually, 2 328 193 (1 483 834 - 3 450 043) patients will be awaiting surgery by 28 February 2021. The cost of delayed procedures is €5.3 (3.1 to 8.0) billion. Safe delivery of surgery during the pandemic will require substantial extra resources costing €526.8 (449.3 to 633.9) million.
As a consequence of the Covid-19 pandemic, provision of elective surgery will be delayed and associated with increased healthcare costs.
COVID-19 疫情期间,除最紧急的手术外,所有手术均被取消。本研究旨在建立模型,以评估因 COVID-19 而取消的手术数量以及重新开展手术活动的情况。
本研究采用医院病例统计数据(2014-2019 年)进行建模。将手术分为四个紧急程度类别。模拟 2020 年 3 月 1 日至 2021 年 2 月 28 日期间实施的手术数量。根据保守假设,使用逐步重新开展择期手术(自 2020 年 6 月 1 日开始)来估算手术例数的不足。使用国民保健服务参考成本计算成本,并以百万或十亿为单位报告。估计值以 95%置信区间报告。
共有 4547534 名(95%置信区间 3318195 至 6250771 名)年龄中位数为 53.5 岁的患者预计在 2020 年 3 月 1 日至 2021 年 2 月 28 日期间接受手术。截至 2020 年 5 月 31 日,已有 749247 例(513564 至 1077448 例)手术被取消。假设择期手术逐渐恢复,到 2021 年 2 月 28 日,将有 2328193 名(1483834 至 3450043 名)患者需要手术。延迟手术的费用为 53 亿欧元(31 至 80 亿欧元)。在大流行期间安全开展手术将需要额外的大量资源,费用为 5268 亿欧元(4493 至 6339 百万欧元)。
由于 COVID-19 疫情,择期手术的开展将被延迟,并导致医疗保健成本增加。